^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

FF-10501-01

i
Other names: FF-10501-01, FF-10501, FF 10501
Associations
Trials
Company:
Fujifilm Holdings, Strategia Therap
Drug class:
IMPDH inhibitor, Cell differentiation stimulant
Associations
Trials
9ms
Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies (clinicaltrials.gov)
P1/2, N=55, Completed, Fujifilm Pharmaceuticals U.S.A., Inc. | N=41 --> 55
Enrollment change
|
FF-10501-01
over5years
FF-10501 induces caspase-8-mediated apoptotic and endoplasmic reticulum stress-mediated necrotic cell death in hematological malignant cells. (PubMed, Int J Hematol)
FF-10501 induced necrotic cell death via endoplasmic reticulum stress in OCI-AML3 cells. The present study is the first to identify intracellular pathways involved in FF-10501-induced cell death.
Journal
|
CASP8 (Caspase 8)
|
FF-10501-01